BFRIW (STOCKS)
Biofrontera Inc. Warrants
$0.024900
+0.001600 (+6.87%)
Prev close: $0.023300
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals Major
- CEO
- Hermann Lübbert, PhD
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 93
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $43.20M |
| Benefits Costs and Expenses | $54.26M |
| Costs And Expenses | $54.32M |
| Nonoperating Income/Loss | $62.00K |
| Operating Expenses | $54.32M |
| Selling, General, and Administrative Expenses | $40.09M |
| Research and Development | $3.41M |
| Other Operating Expenses | $10.82M |
| Operating Income/Loss | -$11.12M |
| Income/Loss From Continuing Operations After Tax | -$11.08M |
| Income/Loss From Continuing Operations Before Tax | -$11.06M |
| Net Income/Loss | -$11.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.09M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.98 |
| Diluted Earnings Per Share | -$0.98 |
| Basic Average Shares | 12,981,312 |
| Diluted Average Shares | 12,981,312 |
| Assets | $24.79M |
| Current Assets | $13.16M |
| Inventory | $1.23M |
| Other Current Assets | $11.93M |
| Noncurrent Assets | $11.63M |
| Fixed Assets | $2.18M |
| Intangible Assets | $2.61M |
| Other Non-current Assets | $6.84M |
| Liabilities | $18.72M |
| Current Liabilities | $10.92M |
| Wages | $3.53M |
| Other Current Liabilities | $7.39M |
| Noncurrent Liabilities | $7.79M |
| Equity | $6.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.07M |
| Liabilities And Equity | $24.79M |
| Net Cash Flow From Operating Activities | -$9.31M |
| Net Cash Flow From Operating Activities, Continuing | -$9.31M |
| Net Cash Flow From Investing Activities | $3.00M |
| Net Cash Flow From Investing Activities, Continuing | $3.00M |
| Net Cash Flow From Financing Activities | $6.81M |
| Net Cash Flow From Financing Activities, Continuing | $6.81M |
| Net Cash Flow | $487.00K |
| Net Cash Flow, Continuing | $487.00K |
| Comprehensive Income/Loss | -$11.09M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.09M |
| Other Comprehensive Income/Loss | $0.00 |